414 related articles for article (PubMed ID: 33270980)
1. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.
Henry BM; Benoit SW; de Oliveira MHS; Lippi G; Favaloro EJ; Benoit JL
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):129-136. PubMed ID: 33270980
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
Marco A; Marco P
J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
[TBL] [Abstract][Full Text] [Related]
3. The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
Mancini I; Baronciani L; Artoni A; Colpani P; Biganzoli M; Cozzi G; Novembrino C; Boscolo Anzoletti M; De Zan V; Pagliari MT; Gualtierotti R; Aliberti S; Panigada M; Grasselli G; Blasi F; Peyvandi F
J Thromb Haemost; 2021 Feb; 19(2):513-521. PubMed ID: 33230904
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
[TBL] [Abstract][Full Text] [Related]
5. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
[TBL] [Abstract][Full Text] [Related]
6. Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.
Grandone E; Vimercati A; Sorrentino F; Colaizzo D; Ostuni A; Ceci O; Capozza M; Tiscia G; De Laurenzo A; Mastroianno M; Cappucci F; Fischetti L; Margaglione M; Cicinelli E; Nappi L
BMC Pregnancy Childbirth; 2022 Feb; 22(1):142. PubMed ID: 35189860
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
Joly BS; Darmon M; Dekimpe C; Dupont T; Dumas G; Yvin E; Beranger N; Vanhoorelbeke K; Azoulay E; Veyradier A
J Thromb Haemost; 2021 Sep; 19(9):2193-2198. PubMed ID: 34219357
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the lipid profile associate with a dysregulated inflammatory, prothrombotic, anti-fibrinolytic state and development of severe acute kidney injury in coronavirus disease 2019 (COVID-19): A study from Cincinnati, USA.
Henry BM; Szergyuk I; de Oliveira MHS; Abosamak MF; Benoit SW; Benoit JL; Lippi G
Diabetes Metab Syndr; 2021; 15(3):863-868. PubMed ID: 33878674
[TBL] [Abstract][Full Text] [Related]
10. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
11. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis.
Prasannan N; Heightman M; Hillman T; Wall E; Bell R; Kessler A; Neave L; Doyle A; Devaraj A; Singh D; Dehbi HM; Scully M
Blood Adv; 2022 Jul; 6(13):4041-4048. PubMed ID: 35543533
[TBL] [Abstract][Full Text] [Related]
12. A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients.
Martín-Rojas RM; Chasco-Ganuza M; Casanova-Prieto S; Delgado-Pinos VE; Pérez-Rus G; Duque-González P; Sancho M; Díez-Martín JL; Pascual-Izquierdo C
Blood Coagul Fibrinolysis; 2021 Oct; 32(7):458-467. PubMed ID: 34310402
[TBL] [Abstract][Full Text] [Related]
13. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.
Henry BM; Szergyuk I; de Oliveira MHS; Lippi G; Benoit JL; Vikse J; Benoit SW
J Med Virol; 2021 Sep; 93(9):5515-5522. PubMed ID: 33974276
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Bauer F; Witzke O; Dittmer U; Bachmann M; Yilmaz S; Dittmer R; Schneppenheim S; Babel N; Budde U; Westhoff TH
Crit Care Med; 2021 May; 49(5):e512-e520. PubMed ID: 33591004
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
Murphy SJX; Lim ST; Hickey F; Kinsella JA; Smith DR; Tierney S; Egan B; Feeley TM; Murphy SM; Collins DR; Coughlan T; O'Neill D; Harbison JA; Madhavan P; O'Neill SM; Colgan MP; O'Donnell JS; O'Sullivan JM; Hamilton G; McCabe DJH
Thromb Haemost; 2021 Jan; 121(1):86-97. PubMed ID: 32932544
[TBL] [Abstract][Full Text] [Related]
16. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
De Cristofaro R; Liuzzo G; Sacco M; Lancellotti S; Pedicino D; Andreotti F
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):285-289. PubMed ID: 33443926
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome.
Taylor A; Vendramin C; Singh D; Brown MM; Scully M
Blood Adv; 2020 Jan; 4(2):398-407. PubMed ID: 31990334
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
[TBL] [Abstract][Full Text] [Related]
19. Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, von Willebrand Factor, and ADAMTS13.
Yang J; Wu Z; Long Q; Huang J; Hong T; Liu W; Lin J
Front Immunol; 2020; 11():610696. PubMed ID: 33343584
[TBL] [Abstract][Full Text] [Related]
20. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.
Favaloro EJ; Henry BM; Lippi G
Semin Thromb Hemost; 2021 Jun; 47(4):400-418. PubMed ID: 33893632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]